Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-22

Clinical Trial Update: Harmony TPV EMEA PMS [NA]

View source ↗

Summary

This update indicates that recruiting is ongoing for the Harmony TPV in the EMEA region under post-market surveillance for severe pulmonary valve regurgitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Harmony TPV

Snippet

Sponsor: Medtronic Cardiovascular | Conditions: Severe Pulmonary Valve Regurgitation | NA | Status: RECRUITING